摘要
目的:探讨双黄连颗粒治疗小儿上呼吸道感染疗效及安全性。方法:将120例患儿随机分为2组,治疗组60例除了常规综合治疗外加用双黄连颗粒治疗,对照组60例采用常规综合治疗。结果:对照组总有效率70.0%,治疗组总有效率93.3%,两组比较差异有统计学意义(P<0.01),治疗组未见与双黄连颗粒有关的不良反应。结论:双黄连颗粒治疗小儿上呼吸道感染疗效显著,值得推广。
Objective: To evaluate the efficacy and safety of Shuanghuanglian powder in treatment of infantile upper respiratory infection. Methods: 120 eases were randomly divided into two groups. Besides the regular therapy, patients in treatment group were administered with Shuanghuanglian powder, but in control group with regular therapy only. Results: The total effective rate of the control group was 70.0%, while that of the treatment group was 93.3 %. There was a significant difference between two groups and no adverse reaction was observed in treatment group. Conclusions: Shuanghuanglian powder is an effective medicine in the treatment of infantile upper respiratory infection and it is worthy of application.
出处
《儿科药学杂志》
CAS
2007年第2期50-52,共3页
Journal of Pediatric Pharmacy
关键词
双黄连颗粒
上呼吸道感染
小儿
Shuanghuanglian powder
Upper respiratory infection
Children